Steven Cohen Cidara Therapeutics, Inc. Transaction History

Point72 Asset Management, L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.75 - $1.98 $1.96 Million - $5.18 Million	-2,618,006 Reduced 67.68%	1,250,000 $1.59 Million
Q3 2022 Nov 14, 2022	SELL	$0.45 - $13.0 $149,397 - $4.32 Million	-331,994 Reduced 7.9%	3,868,006 $2.43 Million
Q4 2021 Feb 14, 2022	BUY	$1.18 - $2.18 $4.96 Million - $9.16 Million	4,200,000 New	4,200,000 $5.33 Million

Ticker CDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,075,696
Market Cap $1.24B
Description
Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.